RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
MoonLake Immunotherapeutics Stock

MoonLake Immunotherapeutics ROA 2024

MoonLake Immunotherapeutics ROA

-0.07

Ticker

MLTX

ISIN

KY61559X1045

In 2024, MoonLake Immunotherapeutics's return on assets (ROA) was -0.07, a -89.48% increase from the -0.65 ROA in the previous year.

MoonLake Immunotherapeutics Aktienanalyse

What does MoonLake Immunotherapeutics do?

MoonLake Immunotherapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding MoonLake Immunotherapeutics's Return on Assets (ROA)

MoonLake Immunotherapeutics's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing MoonLake Immunotherapeutics's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider MoonLake Immunotherapeutics's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in MoonLake Immunotherapeutics’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about MoonLake Immunotherapeutics stock

What is the Return on Assets (ROA) of MoonLake Immunotherapeutics this year?

The Return on Assets (ROA) of MoonLake Immunotherapeutics is -0.07 undefined this year.

What was the ROA of MoonLake Immunotherapeutics compared to the previous year?

The ROA of MoonLake Immunotherapeutics has increased by -89.48% compared to the previous year.

What consequences do high ROA have for investors of MoonLake Immunotherapeutics?

A high ROA is advantageous for investors of MoonLake Immunotherapeutics, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in MoonLake Immunotherapeutics?

A low ROA can be unfavorable for investors of MoonLake Immunotherapeutics as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of MoonLake Immunotherapeutics affect the company?

An increase in ROA of MoonLake Immunotherapeutics can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of MoonLake Immunotherapeutics impact the company?

A reduction in the ROA of MoonLake Immunotherapeutics can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of MoonLake Immunotherapeutics?

Some factors that can influence the ROA of MoonLake Immunotherapeutics include revenue, operating costs, asset structure, and industry average.

Why is the ROA of MoonLake Immunotherapeutics important for investors?

The ROA of MoonLake Immunotherapeutics is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can MoonLake Immunotherapeutics take to improve ROA?

To improve ROA, MoonLake Immunotherapeutics can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does MoonLake Immunotherapeutics pay?

Over the past 12 months, MoonLake Immunotherapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, MoonLake Immunotherapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of MoonLake Immunotherapeutics?

The current dividend yield of MoonLake Immunotherapeutics is .

When does MoonLake Immunotherapeutics pay dividends?

MoonLake Immunotherapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of MoonLake Immunotherapeutics?

MoonLake Immunotherapeutics paid dividends every year for the past 0 years.

What is the dividend of MoonLake Immunotherapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is MoonLake Immunotherapeutics located?

MoonLake Immunotherapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von MoonLake Immunotherapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of MoonLake Immunotherapeutics from 11/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/16/2024.

When did MoonLake Immunotherapeutics pay the last dividend?

The last dividend was paid out on 11/16/2024.

What was the dividend of MoonLake Immunotherapeutics in the year 2023?

In the year 2023, MoonLake Immunotherapeutics distributed 0 USD as dividends.

In which currency does MoonLake Immunotherapeutics pay out the dividend?

The dividends of MoonLake Immunotherapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von MoonLake Immunotherapeutics

Our stock analysis for MoonLake Immunotherapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MoonLake Immunotherapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.